SEC Form 4 · accession 0001189724-16-000014

ICU MEDICAL INC/DE · ICUI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — VP Operations

Period of report

Mar 31, 2016

Accepted (ET)

Mar 31, 2016 · 6:58 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883984

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 31, 2016	X	683	$46.53	A	2,061	D
Common Stock	Mar 31, 2016	S	683	$105.00	D	1,378	D
Common Stock	Mar 31, 2016	X	1,599	$58.79	A	2,977	D
Common Stock	Mar 31, 2016	S	1,599	$105.00	D	1,378	D
Common Stock	Mar 31, 2016	X	17,718	$61.76	A	19,096	D
Common Stock	Mar 31, 2016	S	17,718	$105.00	D	1,378	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F3,F2	$46.53	Mar 31, 2016	X	683	D	—	Feb 1, 2022	Common Stock	683	0	D
Non-Qualified Stock Option (right to buy)^F3,F4	$58.79	Mar 31, 2016	X	1,599	D	—	Feb 24, 2024	Common Stock	1,599	123,401	D
Non-Qualified Stock Option (right to buy)^F3,F2	$61.76	Mar 31, 2016	X	17,718	D	—	Feb 6, 2023	Common Stock	17,718	5,906	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 17,2016.
F2Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
F3Transaction is the exercise of a derivative security; see Column 2.
F4Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days.